MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....
Latest additions worked for GE Healthcare, Humana, and Geisinger Health System. Cleerly has added three new members to its Board of Directors.Full article by Medical Product Outsourcing
The company recruited Kevin M. King, Glenn D. Steele Jr., M.D., Ph.D., and Roy Beveridge, M.D., to help guide the firm as it works to develop and commercialize its digital care pathway solution.
"We welcome Roy, Kevin, and Glenn to our Board of Directors. All three join our board with highly impressive backgrounds as leaders in the healthcare space," said James K. Min, M.D. FACC, founder and CEO of Cleerly. "Having the right experts on our team is key for us to accomplish our goals, and our new board members impeccably fit the bill."
King has nearly three decades of experience serving in leadership roles within medical device, digital healthcare services, and information technologies segments. He worked at iRhythm Technologies for a decade, leading the organization as president and CEO and remains a director of the company. He has also previously served as president, CEO and director at Affymetrix Inc., president and CEO of Thomson Healthcare, and a senior executive at GE Healthcare.
Read full article HERE.
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....
Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.
Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall WellnessAn Interview With Dave Philistin